FDA posts update as mechanism to obtain unapproved Domperidone expected to lose supply in early 2025 Gimoti remains only approved drug shown to reduce hospitalizations, emergency room and medical ...

StockNews.com initiated coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Free Report) in a report released on Friday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock.

Its flagship product, GIMOTI, is the only FDA-approved nasal spray for this condition, offering reliable absorption by bypassing the digestive system—a critical benefit for patients with delayed ...

Evoke Pharma, Inc. (NASDAQ:EVOK – Get Free Report) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $4.93 and traded as low as $4.35.

Nasal sprays are available by prescription or over the counter (OTC). Most products come in a hand-operated pump bottle or squeeze bottle. Knowing how to use a nasal spray is important, as doing it ...

We don't think so. No matter whether you're camping or hanging out in your backyard, it's paramount that you bring protection against the wilds with bug spray. In fact, if you travel to a country ...

There are few things more dispiriting than wearing a new pair of shoes on a bad weather day, then coming home and finding water stains or rings of road salt once they’ve dried. Although there ...